Bahrain vs Northern Africa and Western Asia: Percentage of bloodstream infection due to Escherichia coli resistant
Bahrain
63.0%
in 2022
Northern Africa and Western Asia
52.4%
in 2022
Bahrain rank
9th
Northern Africa and Western Asia rank
7th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Bahrain
- Northern Africa and Western Asia
How they compare
Bahrain currently reports 63.0% against 52.4% in Northern Africa and Western Asia, a difference of 10.6%.
That makes Bahrain's figure about 1.2 times Northern Africa and Western Asia's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Bahrain ahead.
Bahrain ranks 9th and Northern Africa and Western Asia ranks 7th of 50 countries.
Across the 2 decades both report, Bahrain averaged higher in 1 and Northern Africa and Western Asia in 1.
Head to head by decade
| Decade | Bahrain | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.0% | 52.0% | 3.0% | Northern Africa and Western Asia |
| 2020s | 59.9% | 53.7% | 6.3% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Bahrain or Northern Africa and Western Asia?
- Bahrain, at 63.0% against 52.4% in Northern Africa and Western Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Bahrain and Northern Africa and Western Asia?
- 10.6%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Northern Africa and Western Asia?
- 6 years are reported by both, from 2017 to 2022.
- How do Bahrain and Northern Africa and Western Asia rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Bahrain ranks 9th and Northern Africa and Western Asia ranks 7th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.